CD4 and neoplasm: Glucocorticoids likely act at multiple levels to inhibit T cell antitumor immunity, including suppression of antigen-presenting cells, macrophages, and CD4+ helper and CD8+ effector T cells, and we indeed found that both CD4+ and CD8+ T cells are signaled by tumor-derived glucocorticoids.